Sanofi-Aventis awarded $38 million for blowing whistle on EpiPen maker
Big Pharma Sanofi-Aventis was awarded $38.7 million Thursday as its share of a $465 million False Claims Act settlement by Mylan for knowingly misclassifying EpiPen as a generic drug to avoid paying rebates owed to Medicaid.… Continue Reading